THE BCL-2 ANTAGONIST ABT-737 IS HIGHLY EFFECTIVE ON PRIMARY ACUTE LYMPHOBLASTIC LEUKEMIA CELLS

被引：0
|
作者：
Decandia, S. [1 ]
Ricciardi, M. R. [1 ]
Santinelli, S. [1 ]
De Cave, F. [1 ]
Gregorj, C. [1 ]
Bergamo, P. [2 ]
Libotte, F. [1 ]
Vitale, A. [1 ]
Petrucci, M. T.
Milella, M. [1 ,2 ]
Foa, R. [1 ]
Tafuri, A. [1 ]
机构：
[1] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Div Hematol, Rome, Italy
[2] Regina Elena Inst Canc Res, Med Oncol A, Rome, Italy
来源：
HAEMATOLOGICA | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P109
引用
收藏
页码：S83 / S83
页数：1
相关论文
共 50 条
  • [21] ABT-737, a Bcl-2 Selective Inhibitor, and Chloroquine Synergistically Kill Renal Cancer Cells
    Yin, Pei
    Jia, Jinpeng
    Li, Jijun
    Song, Yan
    Zhang, Yiyan
    Chen, Fengkun
    ONCOLOGY RESEARCH, 2016, 24 (01) : 65 - 72
  • [22] FUNCTIONAL EFFECTS OF THE BCL-2/BCL-XL INHIBITOR ABT-737 ON PRIMARY CELLS FROM SMOLDERING AND SYMPTOMATIC MULTIPLE MYELOMA
    Libotte, F.
    Ricciardi, M. R.
    Calabrese, E.
    Santinelli, S.
    Bergamo, P.
    Decandia, S.
    De, Cave F.
    Gregorj, C.
    Federico, V
    Milella, M.
    Foa, R.
    Tafuri, A.
    Petrucci, M. T.
    HAEMATOLOGICA, 2008, 93 : S115 - S115
  • [23] ABT-737, an inhibitor of Bcl-2/Bcl-XL proteins, is cytotoxic in multiple myeloma cells.
    Kline, M
    Kimlinger, T
    Timm, M
    Haug, J
    Lust, JA
    Rajkumar, SV
    Kumar, S
    BLOOD, 2005, 106 (11) : 455A - 455A
  • [24] ABT-737 reverses the acquired radioresistance of breast cancer cells by targeting Bcl-2 and Bcl-xL
    Ji-Yu Li
    Yu-Yang Li
    Wei Jin
    Qing Yang
    Zhi-Ming Shao
    Xing-Song Tian
    Journal of Experimental & Clinical Cancer Research, 31
  • [25] ABT-737 reverses the acquired radioresistance of breast cancer cells by targeting Bcl-2 and Bcl-xL
    Li, Ji-Yu
    Li, Yu-Yang
    Jin, Wei
    Yang, Qing
    Shao, Zhi-Ming
    Tian, Xing-Song
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2012, 31
  • [26] The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin
    Witham, James
    Valenti, Melanie R.
    De-Haven-Brandon, Alexis K.
    Vidot, Susanne
    Eccles, Suzanne A.
    Kaye, Stan B.
    Richardson, Alan
    CLINICAL CANCER RESEARCH, 2007, 13 (23) : 7191 - 7198
  • [27] Topical BCl-2 inhibitor (ABT-737) attenuates skin photoaging in mice
    Yang, Bingyi
    Jiang, Jiao
    Wu, Haijing
    Lu, Qianjin
    EXPERIMENTAL DERMATOLOGY, 2024, 33 (03)
  • [28] Pro-apoptotic activity of the BCL-2 inhibitor ABT-737 on primary multiple myeloma samples
    Ricciardi, M. R.
    Gregorj, C.
    De Cave, F.
    Calabrese, E.
    Santinelli, S.
    Federico, V.
    Bergamo, P.
    Milella, M.
    Foa, R.
    Tafuri, A.
    Petrucci, M. T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 145 - 145
  • [29] Pro-apoptotic effects on CLL (chronic lymphocytic leukemia) of ABT-737, a novel fully synthetic Bcl-2/Bcl-XL antagonist.
    Kitada, S
    Monosov, E
    Chandler, S
    Avery, ED
    Kipps, TJ
    Rosenberg, SH
    Reed, JC
    BLOOD, 2004, 104 (11) : 272A - 273A
  • [30] 'Aerobically poised' leukaemia cells are resistant to the mitochondrial toxin and BCL-2/BCL-XL inhibitor, ABT-737
    Miles, Gareth
    Langlais, Claudia
    MacFarlane, Marion
    Cain, Kelvin
    TOXICOLOGY LETTERS, 2014, 229 : S74 - S74
12345